TABLE 1. Monolayer and anchorage independent growth of NSCLC cell lines with knockdown of RAL GTPase.
Cells were transfected with siRNA against RAL GTPase and plated for proliferation and anchorage independent growth assay (see Materials and Methods). Monolayer growth was measured 4 days after transfection with results representing the mean of 2-3 studies with 4-5 replicates per cell line. Anchorage independent growth results are mean of three experiments.
RALA Knockdown | RALB Knockdown | RALA+B Knockdown | ||||||
---|---|---|---|---|---|---|---|---|
Monolayer Growth | Anchorage Independent Growth | Monolayer Growth | Anchorage Independent Growth | Monolayer Growth | Anchorage Independent Growth | |||
Cell Line | Histology | KRAS | ||||||
H322 | Adenocarcinoma | WT | −52%* | −41.2%* | −33%* | −42.3%* | −46%* | −39%* |
H1703 | Adenocarcinoma | WT | N.S. | N.S. | N.S. | N.S. | N.S. | −52.3%* |
H2228 | Adenocarcinoma | WT | N.S. | N.S. | N.S. | N.S. | N.S. | N.S. |
H292 | Mucoepidermoid | WT | N.S. | No Colony | −23%* | No Colony | N.S. | No Colony |
H4006 | Adenocarcinoma | WT | N.S. | No Colony | N.S. | No Colony | N.S. | No Colony |
Calu3 | Adenocarcinoma | WT | −33%* | No Colony | −36%* | No Colony | −39%* | No Colony |
H2122 | Adenocarcinoma | G12C | −91%* | −97%* | −61%* | −89.2%* | −42%* | −79.6%* |
H358 | Adenocarcinoma | G12C | −24%* | −38%* | N.S. | −27.6%* | −86%* | −83.4%* |
A549 | Adenocarcinoma | G12S | −26%* | −24.5%* | −29%* | N.S. | −27%* | −51.3%* |
H2009 | Adenocarcinoma | G12A | −25%* | −35%* | −19%* | −28.7%* | 28%* | −15.8%* |
H157 | Squamous Cell | G12R | −24%* | N.S. | −19%* | N.S. | N.S. | N.S. |
SW1573 | Alveolar Cell | G12A | N.S. | No Colony | N.S. | No Colony | N.S. | No Colony |
P<0.05 (student's t-test)
(+) indicates increase compared to control
(−) indicates decrease compared to control
“N.S.” is no significant change
“No Colony” indicates cells did not exhibit anchorage independent growth.